Specialty Dosage Drugs

Sep 28, 2017
By Pharmaceutical Technology Editors
Nemera is now authorized to handle, assemble, sterilize, and store pharmaceutical drugs and medicinal products for autoinjector combination products at its facility in Neuenburg, Germany.
Sep 02, 2017
Pharmaceutical Technology
Considerations in selecting a dosage form for drug delivery to the lungs.
Sep 01, 2017
Pharmaceutical Technology
Pulmonary drug delivery is becoming increasingly used. When developing pulmonary drugs, pharmaceutical chemists must consider drug absorption, control of particle size, suitable toxicology models, and patient compliance. The author reviews the issues specific to developing drugs designed for pulmonary delivery and considers how—with the right knowledge and expertise—these challenges can be overcome.
Aug 16, 2017
Equipment and Processing Report
Sensors and communication capability support proper usage, improve compliance, and may enable telemedicine.
Aug 11, 2017
By Pharmaceutical Technology Editors
The Thermo Scientific Pharma mini implant line is built around the Thermo Scientific Pharma mini HME twin-screw micro compounder.
Aug 02, 2017
Pharmaceutical Technology
Characterization of the product and process is key for process development and scale-up of topical drug manufacturing using a QbD approach.
Aug 01, 2017
Pharmaceutical Technology
Successful development requires coordinating and aligning drug and device design, focusing on a complete drug delivery system that meets patients’ needs.
Jul 21, 2017
By Pharmaceutical Technology Editors
The agency recommended a total of 11 drugs at its July meeting, including five orphan drugs.
Jul 05, 2017
By Pharmaceutical Technology Editors
ADV7103 is being evaluated in a Phase III trial in Europe in children and adults with distal renal tubulopathy acidosis. Results from the study are expected in the coming months.
Jul 05, 2017
By Pharmaceutical Technology Editors
SOBI003 is a chemically modified variant of a recombinant human sulfamidase product candidate, using Sobi’s proprietary glycan modification technology.
native1_300x100
lorem ipsum